Par Drugs and Chemicals Limited (NSE:PAR)
89.31
+0.22 (0.25%)
Jun 1, 2026, 3:08 PM IST
Par Drugs and Chemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 418.43 | 275.77 | 366.54 | 222.43 | 162.06 |
Cash & Short-Term Investments | 418.43 | 275.77 | 366.54 | 222.43 | 162.06 |
Cash Growth | 51.73% | -24.76% | 64.79% | 37.25% | -23.42% |
Accounts Receivable | 120.28 | 167.14 | 137.14 | 169.69 | 184.67 |
Other Receivables | 47.48 | - | - | - | 0.74 |
Receivables | 168.87 | 168.13 | 138.09 | 170.45 | 185.91 |
Inventory | 53.73 | 61.94 | 44.21 | 59.68 | 54.98 |
Prepaid Expenses | - | 0.33 | 0.37 | 0.43 | 0.48 |
Other Current Assets | 2.24 | 42.44 | 47.02 | 41.38 | 32.2 |
Total Current Assets | 643.26 | 548.61 | 596.24 | 494.37 | 435.64 |
Property, Plant & Equipment | 371.56 | 389.15 | 413.35 | 386.95 | 343.51 |
Long-Term Investments | 271.36 | 250.7 | 0.12 | 0.1 | 0.1 |
Other Long-Term Assets | 5.94 | 5.44 | 6.41 | 7.26 | 7.65 |
Total Assets | 1,292 | 1,194 | 1,016 | 888.68 | 786.9 |
Accounts Payable | 81.94 | 108.91 | 53.56 | 80.92 | 106.62 |
Accrued Expenses | - | 6.28 | 21 | 20.4 | 8.41 |
Current Income Taxes Payable | - | 45.25 | 49.76 | 37.95 | 33.45 |
Current Unearned Revenue | - | 5.23 | 0.05 | 0.62 | 0.09 |
Other Current Liabilities | 55.5 | 0.02 | 0.02 | 0 | 0 |
Total Current Liabilities | 137.44 | 165.69 | 124.39 | 139.89 | 148.57 |
Pension & Post-Retirement Benefits | - | 2.67 | - | 1.4 | 4.06 |
Long-Term Deferred Tax Liabilities | 32.44 | 35.8 | 35.4 | 35 | 35.5 |
Other Long-Term Liabilities | 2.4 | 0 | - | - | - |
Total Liabilities | 172.28 | 204.15 | 159.79 | 176.3 | 188.13 |
Common Stock | 123.05 | 123.05 | 123.05 | 123.05 | 123.05 |
Additional Paid-In Capital | - | 106.73 | 106.73 | 106.73 | 106.73 |
Retained Earnings | - | 759.29 | 625.86 | 481.93 | 368.31 |
Comprehensive Income & Other | 996.8 | 0.69 | 0.69 | 0.69 | 0.69 |
Total Common Equity | 1,120 | 989.75 | 856.32 | 712.38 | 598.77 |
Shareholders' Equity | 1,120 | 989.75 | 856.32 | 712.38 | 598.77 |
Total Liabilities & Equity | 1,292 | 1,194 | 1,016 | 888.68 | 786.9 |
Net Cash (Debt) | 418.43 | 275.77 | 366.54 | 222.43 | 162.06 |
Net Cash Growth | 51.73% | -24.76% | 64.79% | 37.25% | 26.19% |
Net Cash Per Share | 33.99 | 22.41 | 29.79 | 18.08 | 13.17 |
Filing Date Shares Outstanding | 12.37 | 12.3 | 12.3 | 12.3 | 12.3 |
Total Common Shares Outstanding | 12.37 | 12.3 | 12.3 | 12.3 | 12.3 |
Working Capital | 505.82 | 382.93 | 471.84 | 354.48 | 287.07 |
Book Value Per Share | 90.52 | 80.44 | 69.59 | 57.90 | 48.66 |
Tangible Book Value | 1,120 | 989.75 | 856.32 | 712.38 | 598.77 |
Tangible Book Value Per Share | 90.52 | 80.44 | 69.59 | 57.90 | 48.66 |
Land | - | 31.48 | 31.48 | 6.21 | 3.32 |
Buildings | - | 202.81 | 198.21 | 183.18 | 152.36 |
Machinery | - | 463.15 | 459.94 | 443.59 | 413.09 |
Construction In Progress | - | - | 0.25 | 2.45 | 2.48 |